Mark S. Levi

2.5k total citations · 1 hit paper
25 papers, 1.8k citations indexed

About

Mark S. Levi is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Mark S. Levi has authored 25 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 5 papers in Pharmacology and 4 papers in Molecular Biology. Recurrent topics in Mark S. Levi's work include Chemical synthesis and alkaloids (6 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Alkaloids: synthesis and pharmacology (4 papers). Mark S. Levi is often cited by papers focused on Chemical synthesis and alkaloids (6 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Alkaloids: synthesis and pharmacology (4 papers). Mark S. Levi collaborates with scholars based in United States, Netherlands and United Kingdom. Mark S. Levi's co-authors include Jecko Thachil, Cheng‐Hock Toh, Henry G. Watson, Tom van der Poll, Sander J. H. van Deventer, Hugo Ten Cate, Ronald F. Borne, Margaret A. Brimble, J. Williamson and Madeeha Khan and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Cardiovascular Research and British Journal of Haematology.

In The Last Decade

Mark S. Levi

24 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines for the diagnosis and management of disseminated intravascular coagulation

2009 709 citations Mark S. Levi, Cheng‐Hock Toh et al. British Journal of Haematology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark S. Levi United States	16	427	422	303	249	243	25	1.8k
Karen E. Welty‐Wolf United States	31	243 0.6×	800 1.9×	88 0.3×	1.3k 5.2×	319 1.3×	52	3.1k
Nicolas von Ahsen Germany	31	337 0.8×	340 0.8×	55 0.2×	825 3.3×	74 0.3×	89	2.8k
Giulia Benedetti Italy	23	119 0.3×	292 0.7×	125 0.4×	421 1.7×	63 0.3×	67	3.0k
Sylvie Saivin France	23	101 0.2×	366 0.9×	243 0.8×	160 0.6×	54 0.2×	75	1.7k
Pal B. Szecsi Denmark	25	246 0.6×	125 0.3×	101 0.3×	258 1.0×	51 0.2×	80	2.0k
Luci Maria Sant’Ana Dusse Brazil	29	605 1.4×	231 0.5×	152 0.5×	397 1.6×	20 0.1×	136	2.9k
Gabriele Halwachs‐Baumann Austria	20	162 0.4×	399 0.9×	30 0.1×	150 0.6×	88 0.4×	51	1.4k
Donald E. Macfarlane United States	30	646 1.5×	311 0.7×	178 0.6×	819 3.3×	23 0.1×	96	3.0k
Joannes J.M. Marx Netherlands	32	1.7k 4.0×	179 0.4×	44 0.1×	445 1.8×	82 0.3×	96	3.2k
Eric P. Schmidt United States	32	140 0.3×	1.2k 2.8×	87 0.3×	773 3.1×	1.1k 4.4×	92	3.8k

Countries citing papers authored by Mark S. Levi

Since Specialization

Citations

This map shows the geographic impact of Mark S. Levi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Levi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Levi more than expected).

Fields of papers citing papers by Mark S. Levi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Levi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Levi. The network helps show where Mark S. Levi may publish in the future.

Co-authorship network of co-authors of Mark S. Levi

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Levi. A scholar is included among the top collaborators of Mark S. Levi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Levi. Mark S. Levi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Levendowski, Daniel J., Arie Oksenberg, Claudio Vicini, et al.. (2018). A systematic comparison of factors that could impact treatment recommendations for patients with Positional Obstructive Sleep Apnea (POSA). Sleep Medicine. 50. 145–151. 25 indexed citations

Levi, Mark S., et al.. (2017). An improved size exclusion-HPLC method for molecular size distribution analysis of immunoglobulin G using sodium perchlorate in the eluent. Journal of Pharmaceutical and Biomedical Analysis. 138. 330–343. 15 indexed citations

Levi, Mark S., Joseph P. Hanig, Nysia I. George, et al.. (2013). Serum myoglobin, but not lipopolysaccharides, is predictive of AMPH-induced striatal neurotoxicity. NeuroToxicology. 37. 40–50. 6 indexed citations

Bowyer, John F., et al.. (2012). A Visual Description of the Dissection of the Cerebral Surface Vasculature and Associated Meninges and the Choroid Plexus from Rat Brain. Journal of Visualized Experiments. e4285–e4285. 27 indexed citations

Paris, Daniel H., Vilada Chansamouth, Pruksa Nawtaisong, et al.. (2011). Coagulation and inflammation in scrub typhus and murine typhus—a prospective comparative study from Laos. Clinical Microbiology and Infection. 18(12). 1221–1228. 32 indexed citations

Levi, Mark S., et al.. (2009). Rapid one-step purification of native dimeric ALS-associated human Cu/Zn superoxide dismutase from transgenic rat tissues. Amyotrophic Lateral Sclerosis. 11(3). 283–288. 3 indexed citations

Levi, Mark S., Cheng‐Hock Toh, Jecko Thachil, & Henry G. Watson. (2009). Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Journal of Haematology. 145(1). 24–33. 709 indexed citations breakdown →

Borne, Ronald F., et al.. (2009). Solution-Phase Parallel Synthesis of N-Arylisoquinuclidines. Letters in Drug Design & Discovery. 6(1). 78–81.

Berend, Kenrick & Mark S. Levi. (2008). Is it time to celebrate a century of blood pressure management?. Nephrology Dialysis Transplantation. 23(8). 2558–2562. 1 indexed citations

10.

Khan, Madeeha, et al.. (2008). Isoquinuclidines: A Review of Chemical and Pharmacological Properties. 753–787. 25 indexed citations

11.

Khan, Madeeha, et al.. (2006). Synthesis of isoquinuclidine analogs of chloroquine: Antimalarial and antileishmanial activity. Bioorganic & Medicinal Chemistry. 15(11). 3919–3925. 34 indexed citations

12.

Brimble, Margaret A. & Mark S. Levi. (2006). A Review of Agents Patented for their Neuroprotective Properties. PubMed. 1(2). 139–146. 4 indexed citations

13.

Levi, Mark S. & Margaret A. Brimble. (2004). A Review of Neuroprotective Agents. Current Medicinal Chemistry. 11(18). 2383–2397. 42 indexed citations

14.

Brimble, Margaret A., et al.. (2004). Synthesis and pharmacological evaluation of glycine-modified analogues of the neuroprotective agent glycyl-l-prolyl-l-glutamic acid (GPE). Bioorganic & Medicinal Chemistry. 13(2). 533–548. 23 indexed citations

15.

Levi, Mark S., Momin Khan, & Ronald F. Borne. (2004). Solution-Phase Parallel Synthesis of N-Substituted Isoquinuclidines. Letters in Drug Design & Discovery. 1(4). 384–386. 2 indexed citations

16.

Levi, Mark S.. (2003). Infection and inflammation and the coagulation system. Cardiovascular Research. 60(1). 26–39. 400 indexed citations

17.

Levi, Mark S.. (2003). Three-way chemometric method study and UV-Vis absorbance for the study of simultaneous degradation of anthocyanins in flowers of the Hibiscus rosa-sinensys species. Talanta. 62(2). 299–305. 44 indexed citations

18.

Levi, Mark S. & Ronald F. Borne. (2002). A Review of Chemical Agents in the Pharmacotherapy of Addiction. Current Medicinal Chemistry. 9(20). 1807–1818. 30 indexed citations

19.

Levi, Mark S., Ronald F. Borne, & J. Williamson. (2001). A Review of Cancer Chemopreventive Agents. Current Medicinal Chemistry. 8(11). 1349–1362. 58 indexed citations

20.

Levi, Mark S., Tom van der Poll, Hugo Ten Cate, & Sander J. H. van Deventer. (1997). The cytokine‐mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. European Journal of Clinical Investigation. 27(1). 3–9. 255 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact